Mabano, Concepcion P.
HRN: 20-30-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
CEFTAZIDIME 1GM (VIAL)
05/13/2022
05/21/2022
IV
1gm
Q8
Pleural Effusion Right; Allergic Reaction To Pip-Taz
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes